Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lawrence J. Jennings"'
Publikováno v:
Archives of Pathology & Laboratory Medicine. 142:1517-1523
Context.— Melanotic schwannoma (MS) is a nerve sheath tumor with a uniform composition of variably melanin-producing Schwann cells and metastatic potential. The MS is an uncommon neoplasm, accounting for less than 1% of all nerve sheath tumors, wit
Autor:
Angela N. Bartley, Patricia Vasalos, Jason D. Merker, Neal I. Lindeman, Alex J. Rai, Rakesh Nagarajan, Julia A. Bridge, Alexander J. Lazar, Annette S. Kim, Mark J. Routbort, Joel T. Moncur, Suzanne Kamel-Reid, Lawrence J. Jennings
Publikováno v:
Archives of Pathology & Laboratory Medicine. 141:1679-1685
Context.— Detection of acquired variants in cancer is a paradigm of precision medicine, yet little has been reported about clinical laboratory practices across a broad range of laboratories. Objective.— To use College of American Pathologists pro
Autor:
Diane L. Persons, Michelle M Dolan, Julia A. Bridge, Joel T. Moncur, Patricia Vasalos, Rhona J. Souers, Katherine B. Geiersbach, Karen D. Tsuchiya, Lawrence J. Jennings
Publikováno v:
Archives of pathologylaboratory medicine. 142(10)
Context.—Fluorescence in situ hybridization (FISH) and brightfield in situ hybridization (ISH) are 2 clinically approved laboratory methods for detecting ERBB2 (HER2) amplification in breast cancer.Objective.—To compare the performance of FISH an
Autor:
Mu Shan, Lawrence J. Jennings, Amanda L. Treece, Neal I. Lindeman, Patricia Vasalos, David L. Rimm, Rondell P. Graham
Publikováno v:
Archives of pathologylaboratory medicine. 142(2)
Context.— Recurrent epidermal growth factor receptor (EGFR) mutations are seen in a subset of pulmonary adenocarcinomas. These mutations are targeted by EGFR inhibitors and are a biomarker for response to EGFR inhibitor therapies. Initial data have
Autor:
Margaret L. Gulley, Cherie Paquette, Patricia Vasalos, Neal I. Lindeman, Amanda L. Treece, Lawrence J. Jennings, Angela N. Bartley
Publikováno v:
Archives of pathologylaboratory medicine. 141(5)
Context.—With enormous growth in the field of molecular pathology, the reporting of results gleaned from this testing is essential to guide patient care.Objective.—To examine molecular reports from laboratories participating in proficiency testin
Autor:
Patricia Vasalos, Lawrence J. Jennings, Theresa A. Boyle, Linda Sabatini, Kevin C. Halling, Julia A. Bridge, Jan A. Nowak
Publikováno v:
Archives of Pathology & Laboratory Medicine. 138:363-370
The College of American Pathologists surveys are the largest laboratory peer comparison programs in the world. These programs allow laboratories to regularly evaluate their performance and improve the accuracy of the patient test results they provide
Autor:
Hollis Viray, Meera Hameed, Kevin Li, Julia A. Bridge, Patricia Vasalos, David L. Rimm, Lawrence J. Jennings, Kevin C. Halling, Thomas A. Long
Publikováno v:
Archives of pathologylaboratory medicine. 137(11)
The fraction of malignant cells in tumor tissue submitted for tests of genetic alterations is a critical variable in testing accuracy. That fraction is currently determined by pathologist visual estimation of the percentage of malignant cells. Inaccu
Autor:
Diane L. Persons, Frederick A. Smith, Kevin C. Halling, Suzanne Kamel-Reid, Lawrence J. Jennings
Publikováno v:
Archives of pathologylaboratory medicine. 136(1)
Context.—Monitoring minimal residual disease by quantitative reverse transcription polymerase chain reaction has proven clinically useful, but as yet there are no Food and Drug Administration–approved tests. Guidelines have been published that pr
Publikováno v:
Archives of pathologylaboratory medicine. 133(5)
Context.—The use of DNA- and RNA-based tests continues to grow for applications as varied as inherited disease, infectious disease, cancer, identity testing, human leukocyte antigen typing, and pharmacogenetics. Progress is driven in part by the hu
Publikováno v:
Archives of Pathology & Laboratory Medicine. 129:e105-e106